Identification of Susceptibility Genes in Hepatic Cancer Using Whole Exome Sequencing and Risk Prediction Model Construction

1. European Association for The Study Of The Liver, European Organization For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908-43. DOI: 10.1016/j.jhep.2011.12.00110.1016/j.jhep.2011.12.00122424438Search in Google Scholar

2. Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl. 2004;10(2 Suppl 1):S39-45. DOI: 10.1002/lt.2004010.1002/lt.2004014762838Search in Google Scholar

3. Ruan SM, Gong SP, Lin SQ. Analysis of Malignant Tumor Incidence in Jinan City in 2012. Chinese Journal of Cancer prevention and treatment. 2014;14:1063-7.Search in Google Scholar

4. Wu XQ, Mi HF, Rong B, Chen GW, Dai L, Chen ZL, et al. Analysis of Hepatic cancer death among residents in Xiamen city in 2002-2011. Chinese Journal of Disease Control ---amp---Prevention. 2014;07:613-6.Search in Google Scholar

5. Zou YP, Ge S. A novel molecular marker-SNPs and its application. Biodiversity Science. 2003;11(5):370-82.10.17520/biods.2003045Search in Google Scholar

6. Schuster SC. Next generation sequencing transforms today’s biology. Nat Methods. 2008;5(1):16-8. DOI: 10.1038/nmeth115610.1038/nmeth115618165802Search in Google Scholar

7. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature. 2009;461(7261):272-6. DOI: 10.1038/nature0825010.1038/nature08250284477119684571Search in Google Scholar

8. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet. 2010;42(1): 30-5. DOI: 10.1038/ng.49910.1038/ng.499284788919915526Search in Google Scholar

9. Summerer D, Schracke N, Wu H, Cheng Y, Bau S, Stahler CF, et al. Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform. Genomics. 2010;95(4):241-6. DOI: 10.1016/j. ygeno.2010.01.00610.1016/j.ygeno.2010.01.006Search in Google Scholar

10. Glessner JT, Bick AG, Ito K, Homsy J, Rodriguez-Murillo L, Fromer M, et al. Increased frequency of de novo copy number variants in congenital heart disease by integrative analysis of single nucleotide polymorphism array and exome sequence data. Circ Res. 2014;115(10):884-96. DOI: 10.1161/CIRCRESAHA.115.30445810.1161/CIRCRESAHA.115.304458420919025205790Search in Google Scholar

11. Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46(2):161-5. DOI: 10.1038/ng.286810.1038/ng.2868398231624413733Search in Google Scholar

12. Radmacher MD, Mcshane LM, Simon R. A Paradigm for Class Prediction Using Gene Expression Profiles. J Comput Biol, 2002;9(3):505-11. DOI: 10.1089/10665270276013859210.1089/10665270276013859212162889Search in Google Scholar

13. Dudoit S, Fridlyand J, Speed TP. Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data. J Am Stat Assoc, 2002; 97(457):77-87. DOI: 10.1198/01621450275347924810.1198/016214502753479248Search in Google Scholar

14. Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A. 2003;100(17):9991-6. DOI: 10.1073/pnas.173200810010.1073/pnas.173200810018791212900505Search in Google Scholar

15. Sun SG, Tong ET. Advances in etiology and pathogenesis of multiple sclerosis. J Clin Neurol. 1995;8:5.Search in Google Scholar

16. Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe’er I, Floratos A, et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet. 2009 Jul;41(7):816-9. DOI: 10.1038/ng.37910.1038/ng.37919483685Search in Google Scholar

17. Liu X, Yu L, Han C, Lu S, Zhu G, Su H, et al. Polymorphisms otablef HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection. Clin Res Hepatol Gastroenterol. 2016 Dec;40(6): 739-47. DOI: 10.1016/j.clinre.2016.04.00510.1016/j.clinre.2016.04.00527288300Search in Google Scholar

18. Swets M, König MH, Zaalberg A, Dekker-Ensink NG, Gelderblom H, van de Velde CJ, et al. HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases. Hum Immunol. 2016 Sep;77(9): 773-9. DOI: 10.1016/j.humimm.2016.03.00110.1016/j.humimm.2016.03.00126968946Search in Google Scholar

19. Karra VK, Chowdhury SJ, Ruttala R, Gumma PK, Polipalli SK, Chakravarti A, et al. HLA-DQA1 ---amp--- DQB1 variants associated with hepatitis B virus-related chronic hepatitis, cirrhosis ---amp--- hepatocellular carcinoma. Indian J Med Res. 2018 Jun;147 (6):573-80. DOI: 10.4103/ijmr.IJMR_1644_1510.4103/ijmr.IJMR_1644_15611814630168489Search in Google Scholar

20. Kang X, Wang F, Lan X, Li X, Zheng S, Lv Z, et al. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma in Vitro and in Vivo. Int J Med Sci. 2018 Jan 1;15(1):69-76. DOI: 10.7150/ijms.2111310.7150/ijms.21113576574129333089Search in Google Scholar

21. Liu L, Zhang J, Lu Y, Fang C, Li S, Lin J. Correlation between ASCC3 gene polymorphisms and Chronic Hepatitis B in a Chinese Han population. PLoS One. 2015 Nov 4;10(11):e0141861. DOI: 10.1371/journal. pone.014186110.1371/journal.pone.0141861Search in Google Scholar